Hull & East Yorkshire Hosp (replace)

Hu16 5JQ (Yorkshire and The Humber)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£244,204

Feb 14 - Jan 20

Multi-centre Randomized Controlled Trial of angiotensin converting enzyme inhibitor (ACEi) /angiotensin receptor blocker (ARB) - withdrawal in chronic kidney disease – STOP-ACEi-STUDY (SAS)

MRC award to Hull & East Yorkshire Hosp (replace) and Sunil Bhandari

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}